| The PROCLIPI international registry of early‐stage mycosis fungoides identifies substantial diagnostic delay in most patients JJ Scarisbrick, P Quaglino, HM Prince, E Papadavid, E Hodak, M Bagot, ... British Journal of Dermatology 181 (2), 350-357, 2019 | 175 | 2019 |
| Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium P Quaglino, M Maule, HM Prince, P Porcu, S Horwitz, M Duvic, R Talpur, ... Annals of Oncology 28 (10), 2517-2525, 2017 | 137 | 2017 |
| European Guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology–Part II E Schmidt, H Rashid, AV Marzano, A Lamberts, G Di Zenzo, GFH Diercks, ... Journal of the European Academy of Dermatology and Venereology 35 (10), 1926 …, 2021 | 101 | 2021 |
| European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology–Part I H Rashid, A Lamberts, L Borradori, S Alberti‐Violetti, RJ Barry, M Caproni, ... Journal of the European Academy of Dermatology and Venereology 35 (9), 1750-1764, 2021 | 84 | 2021 |
| Characteristics associated with significantly worse quality of life in mycosis fungoides/Sezary syndrome from the Prospective Cutaneous Lymphoma International Prognostic Index … K Molloy, C Jonak, F Woei‐A‐Jin, E Guenova, AM Busschots, A Bervoets, ... British Journal of Dermatology 182 (3), 770-779, 2020 | 84 | 2020 |
| Treatment of early‐stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study P Quaglino, HM Prince, R Cowan, M Vermeer, E Papadavid, M Bagot, ... British Journal of Dermatology 184 (4), 722-730, 2021 | 53 | 2021 |
| Clinicopathological and molecular study of primary cutaneous CD4+ small/medium‐sized pleomorphic T‐cell lymphoma S Alberti‐Violetti, CA Torres‐Cabala, R Talpur, L Corti, D Fanoni, ... Journal of cutaneous pathology 43 (12), 1121-1130, 2016 | 45 | 2016 |
| Advanced-stage mycosis fungoides and Sézary syndrome: survival and response to treatment S Alberti-Violetti, R Talpur, M Schlichte, D Sui, M Duvic Clinical Lymphoma Myeloma and Leukemia 15 (6), e105-e112, 2015 | 44 | 2015 |
| Clinical characteristics, risk factors and long-term outcome of 114 patients with folliculotropic mycosis fungoides I Wieser, C Wang, S Alberti-Violetti, G Lyons, C Tran, R Talpur, M Duvic Archives of dermatological research 309, 453-459, 2017 | 43 | 2017 |
| A literature revision in primary cutaneous B-cell lymphoma R La Selva, SA Violetti, C Delfino, V Grandi, S Cicchelli, C Tomasini, ... Indian Journal of Dermatology 62 (2), 146-157, 2017 | 43 | 2017 |
| Phenotypical markers, molecular mutations, and immune microenvironment as targets for new treatments in patients with mycosis fungoides and/or Sézary syndrome P Quaglino, P Fava, A Pileri, V Grandi, M Sanlorenzo, V Panasiti, ... Journal of Investigative Dermatology 141 (3), 484-495, 2021 | 39 | 2021 |
| CCR4 in cutaneous T‐cell lymphoma: Therapeutic targeting of a pathogenic driver JP Nicolay, JD Albrecht, S Alberti‐Violetti, E Berti European Journal of Immunology 51 (7), 1660-1671, 2021 | 35 | 2021 |
| Primary cutaneous acral CD8 positive T‐cell lymphoma with extra‐cutaneous involvement: a long‐standing case with an unexpected progression S Alberti‐Violetti, D Fanoni, M Provasi, L Corti, L Venegoni, E Berti Journal of Cutaneous Pathology 44 (11), 964-968, 2017 | 34 | 2017 |
| Should we be imaging lymph nodes at initial diagnosis of early‐stage mycosis fungoides? Results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI … E Hodak, S Sherman, E Papadavid, M Bagot, C Querfeld, P Quaglino, ... British Journal of Dermatology 184 (3), 524-531, 2021 | 22 | 2021 |
| Cutaneous and systemic vasculitides in dermatology: a histological perspective. S Alberti-Violetti, E Berti, AV Marzano Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale, Societa …, 2018 | 22 | 2018 |
| The microenvironment’s role in mycosis fungoides and Sézary syndrome: from progression to therapeutic implications A Pileri, A Guglielmo, V Grandi, SA Violetti, D Fanoni, P Fava, ... Cells 10 (10), 2780, 2021 | 21 | 2021 |
| Standardization of regimens in Narrowband UVB and PUVA in early stage mycosis fungoides: position paper from the Italian Task Force for Cutaneous Lymphomas V Grandi, P Fava, S Rupoli, S Alberti Violetti, L Canafoglia, P Quaglino, ... Journal of the European Academy of Dermatology and Venereology 32 (5), 683-691, 2018 | 17 | 2018 |
| Cutaneous lupus erythematosus induced by adalimumab P Vezzoli, SA Violetti, SM Serini, S Muratori, E Berti, C Crosti The Journal of dermatology 38 (3), 283-284, 2011 | 16 | 2011 |
| Array‐based CGH of primary cutaneous CD8+ aggressive EPIDERMO‐tropic cytotoxic T‐cell lymphoma D Fanoni, L Corti, S Alberti‐Violetti, CP Tensen, L Venegoni, M Vermeer, ... Genes, Chromosomes and Cancer 57 (12), 622-629, 2018 | 14 | 2018 |
| Interleukin-17 vs. interleukin-23 Inhibitors in pustular and erythrodermic psoriasis: a retrospective, multicentre cohort study G Avallone, CA Maronese, G Murgia, CG Carrera, L Mastorino, ... Journal of Clinical Medicine 12 (4), 1662, 2023 | 11 | 2023 |
Emilio BertiProf. Ordinario di Dermatologia Università degli Studi di MilanoVerified email at unimi.it
